aim rx ltd
aim rx ltd Company Information
Company Number
10085603
Next Accounts
Oct 2025
Industry
Dispensing chemist in specialised stores
Shareholders
bbe developments ltd
Group Structure
View All
Contact
Registered Address
appleton village pharmacy, appleton village, widnes, cheshire, WA8 6EQ
Website
-aim rx ltd Estimated Valuation
Pomanda estimates the enterprise value of AIM RX LTD at £6.1m based on a Turnover of £15.7m and 0.39x industry multiple (adjusted for size and gross margin).
aim rx ltd Estimated Valuation
Pomanda estimates the enterprise value of AIM RX LTD at £1.2m based on an EBITDA of £191.7k and a 6.15x industry multiple (adjusted for size and gross margin).
aim rx ltd Estimated Valuation
Pomanda estimates the enterprise value of AIM RX LTD at £5.4m based on Net Assets of £2.2m and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Aim Rx Ltd Overview
Aim Rx Ltd is a live company located in widnes, WA8 6EQ with a Companies House number of 10085603. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in March 2016, it's largest shareholder is bbe developments ltd with a 100% stake. Aim Rx Ltd is a young, mid sized company, Pomanda has estimated its turnover at £15.7m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Aim Rx Ltd Health Check
Pomanda's financial health check has awarded Aim Rx Ltd a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 3 areas for improvement. Company Health Check FAQs
7 Strong
2 Regular
3 Weak
Size
annual sales of £15.7m, make it larger than the average company (£12.9m)
£15.7m - Aim Rx Ltd
£12.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 5%, show it is growing at a slower rate (7.2%)
- Aim Rx Ltd
7.2% - Industry AVG
Production
with a gross margin of 30.8%, this company has a comparable cost of product (30.6%)
30.8% - Aim Rx Ltd
30.6% - Industry AVG
Profitability
an operating margin of 0.5% make it less profitable than the average company (2.1%)
0.5% - Aim Rx Ltd
2.1% - Industry AVG
Employees
with 145 employees, this is above the industry average (81)
145 - Aim Rx Ltd
81 - Industry AVG
Pay Structure
on an average salary of £18.3k, the company has a lower pay structure (£23k)
£18.3k - Aim Rx Ltd
£23k - Industry AVG
Efficiency
resulting in sales per employee of £108.4k, this is less efficient (£131.9k)
£108.4k - Aim Rx Ltd
£131.9k - Industry AVG
Debtor Days
it gets paid by customers after 29 days, this is near the average (30 days)
29 days - Aim Rx Ltd
30 days - Industry AVG
Creditor Days
its suppliers are paid after 75 days, this is slower than average (67 days)
75 days - Aim Rx Ltd
67 days - Industry AVG
Stock Days
it holds stock equivalent to 15 days, this is less than average (29 days)
15 days - Aim Rx Ltd
29 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 33 weeks, this is more cash available to meet short term requirements (16 weeks)
33 weeks - Aim Rx Ltd
16 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 53.9%, this is a lower level of debt than the average (61%)
53.9% - Aim Rx Ltd
61% - Industry AVG
AIM RX LTD financials
Aim Rx Ltd's latest turnover from January 2024 is £15.7 million and the company has net assets of £2.2 million. According to their latest financial statements, Aim Rx Ltd has 145 employees and maintains cash reserves of £1.6 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jan 2024 | Jan 2023 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Mar 2017 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | 15,722,328 | 17,831,153 | ||||||
| Other Income Or Grants | 0 | 0 | ||||||
| Cost Of Sales | 10,881,673 | 12,041,831 | ||||||
| Gross Profit | 4,840,655 | 5,789,322 | ||||||
| Admin Expenses | 4,762,063 | 5,481,572 | ||||||
| Operating Profit | 78,592 | 307,750 | ||||||
| Interest Payable | 235 | 3,505 | ||||||
| Interest Receivable | 0 | 0 | ||||||
| Pre-Tax Profit | 525,944 | 303,079 | ||||||
| Tax | -38,879 | -32,800 | ||||||
| Profit After Tax | 487,065 | 270,279 | ||||||
| Dividends Paid | 418,210 | 2,299,438 | ||||||
| Retained Profit | 68,855 | -2,029,159 | ||||||
| Employee Costs | 2,654,679 | 3,265,611 | ||||||
| Number Of Employees | 145 | 118 | 121 | 123 | 108 | 101 | ||
| EBITDA* | 191,725 | 444,926 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jan 2024 | Jan 2023 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Mar 2017 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 424,613 | 440,746 | 744,958 | 355,937 | 373,811 | 404,660 | 368,241 | 0 |
| Intangible Assets | 220,875 | 249,375 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 423,134 | 423,134 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 1,068,622 | 1,113,255 | 744,958 | 355,937 | 373,811 | 404,660 | 368,241 | 0 |
| Stock & work in progress | 451,508 | 433,029 | 372,546 | 362,364 | 372,124 | 321,868 | 332,833 | 0 |
| Trade Debtors | 1,278,865 | 1,304,169 | 2,079,966 | 533,562 | 1,856,437 | 1,646,828 | 1,395,562 | 0 |
| Group Debtors | 0 | 0 | 1,468,051 | 463,561 | 341,933 | 0 | 0 | 0 |
| Misc Debtors | 320,873 | 321,988 | 479,226 | 350,403 | 237,252 | 339,828 | 298,355 | 0 |
| Cash | 1,645,171 | 1,319,311 | 1,193,964 | 2,689,873 | 363,109 | 249,135 | 474,919 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 3,696,417 | 3,378,497 | 5,593,753 | 4,399,763 | 3,170,855 | 2,557,659 | 2,501,669 | 0 |
| total assets | 4,765,039 | 4,491,752 | 6,338,711 | 4,755,700 | 3,544,666 | 2,962,319 | 2,869,910 | 0 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 2,263,870 | 2,114,603 | 1,746,793 | 1,642,547 | 1,469,922 | 1,424,705 | 1,120,070 | 0 |
| Group/Directors Accounts | 0 | 0 | 2,317 | 5,000 | 5,000 | 273,135 | 1,012,486 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 280,862 | 235,629 | 383,145 | 346,599 | 364,422 | 258,459 | 190,402 | 0 |
| total current liabilities | 2,544,732 | 2,350,232 | 2,132,255 | 1,994,146 | 1,839,344 | 1,956,299 | 2,322,958 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 24,765 | 14,833 | 50,610 | 28,776 | 28,088 | 29,353 | 21,948 | 0 |
| total long term liabilities | 24,765 | 14,833 | 50,610 | 28,776 | 28,088 | 29,353 | 21,948 | 0 |
| total liabilities | 2,569,497 | 2,365,065 | 2,182,865 | 2,022,922 | 1,867,432 | 1,985,652 | 2,344,906 | 0 |
| net assets | 2,195,542 | 2,126,687 | 4,155,846 | 2,732,778 | 1,677,234 | 976,667 | 525,004 | 0 |
| total shareholders funds | 2,195,542 | 2,126,687 | 4,155,846 | 2,732,778 | 1,677,234 | 976,667 | 525,004 | 0 |
| Jan 2024 | Jan 2023 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Mar 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | 78,592 | 307,750 | ||||||
| Depreciation | 84,633 | 101,551 | 71,745 | 38,124 | 33,980 | 34,160 | 27,512 | |
| Amortisation | 28,500 | 35,625 | 0 | 0 | 0 | 0 | 0 | |
| Tax | -38,879 | -32,800 | ||||||
| Stock | 18,479 | 433,029 | 10,182 | -9,760 | 50,256 | -10,965 | 332,833 | 0 |
| Debtors | -26,419 | 1,626,157 | 2,679,717 | -1,088,096 | 448,966 | 292,739 | 1,693,917 | 0 |
| Creditors | 149,267 | 2,114,603 | 104,246 | 172,625 | 45,217 | 304,635 | 1,120,070 | 0 |
| Accruals and Deferred Income | 45,233 | 235,629 | 36,546 | -17,823 | 105,963 | 68,057 | 190,402 | 0 |
| Deferred Taxes & Provisions | 9,932 | 14,833 | 21,834 | 688 | -1,265 | 7,405 | 21,948 | 0 |
| Cash flow from operations | 365,218 | 718,005 | ||||||
| Investing Activities | ||||||||
| capital expenditure | 0 | 0 | ||||||
| Change in Investments | 0 | 423,134 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | 0 | -423,134 | ||||||
| Financing Activities | ||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | -2,683 | 0 | -268,135 | -739,351 | 1,012,486 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||
| interest | -235 | -3,505 | ||||||
| cash flow from financing | -235 | 4,152,341 | ||||||
| cash and cash equivalents | ||||||||
| cash | 325,860 | 1,319,311 | -1,495,909 | 2,326,764 | 113,974 | -225,784 | 474,919 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 325,860 | 1,319,311 | -1,495,909 | 2,326,764 | 113,974 | -225,784 | 474,919 | 0 |
aim rx ltd Credit Report and Business Information
Aim Rx Ltd Competitor Analysis
Perform a competitor analysis for aim rx ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mid companies, companies in WA8 area or any other competitors across 12 key performance metrics.
aim rx ltd Ownership
AIM RX LTD group structure
Aim Rx Ltd has no subsidiary companies.
Ultimate parent company
AIM RX LTD
10085603
aim rx ltd directors
Aim Rx Ltd currently has 2 directors. The longest serving directors include Mr Paul Doherty (Oct 2016) and Mr Martin Stratton (Feb 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Paul Doherty | England | 44 years | Oct 2016 | - | Director |
| Mr Martin Stratton | England | 50 years | Feb 2017 | - | Director |
P&L
January 2024turnover
15.7m
-12%
operating profit
78.6k
-74%
gross margin
30.8%
-5.17%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
January 2024net assets
2.2m
+0.03%
total assets
4.8m
+0.06%
cash
1.6m
+0.25%
net assets
Total assets minus all liabilities
Similar Companies
aim rx ltd company details
company number
10085603
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
March 2016
age
8
incorporated
UK
ultimate parent company
accounts
Medium Company
last accounts submitted
January 2024
previous names
N/A
accountant
-
auditor
LLYAS PATEL (ACCOUNTANTS) LIMITED
address
appleton village pharmacy, appleton village, widnes, cheshire, WA8 6EQ
Bank
-
Legal Advisor
-
aim rx ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to aim rx ltd.
aim rx ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
